Aag DNA Glycosylase Promotes Alkylation-Induced Tissue Damage Mediated by Parp1

English version České info

Alkylating agents comprise a major class of front-line cancer chemotherapeutic compounds, and while these agents effectively kill tumor cells, they also damage healthy tissues. Although base excision repair (BER) is essential in repairing DNA alkylation damage, under certain conditions, initiation of BER can be detrimental. Here we illustrate that the alkyladenine DNA glycosylase (AAG) mediates alkylation-induced tissue damage and whole-animal lethality following exposure to alkylating agents. Aag-dependent tissue damage, as observed in cerebellar granule cells, splenocytes, thymocytes, bone marrow cells, pancreatic β-cells, and retinal photoreceptor cells, was detected in wild-type mice, exacerbated in Aag transgenic mice, and completely suppressed in Aag^−/− mice. Additional genetic experiments dissected the effects of modulating both BER and Parp1 on alkylation sensitivity in mice and determined that Aag acts upstream of Parp1 in alkylation-induced tissue damage; in fact, cytotoxicity in WT and Aag transgenic mice was abrogated in the absence of Parp1. These results provide in vivo evidence that Aag-initiated BER may play a critical role in determining the side-effects of alkylating agent chemotherapies and that Parp1 plays a crucial role in Aag-mediated tissue damage.

Vyšlo v časopise: Aag DNA Glycosylase Promotes Alkylation-Induced Tissue Damage Mediated by Parp1. PLoS Genet 9(4): e32767. doi:10.1371/journal.pgen.1003413
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003413

Souhrn

Zdroje

1. HoeijmakersJ (2009) DNA damage, aging, and cancer. N Engl J Med 361: 1475–1485.

2. HewishM, LordCJ, MartinSA, CunninghamD, AshworthA (2010) Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol 7: 197–208.

3. RoyR, ChunJ, PowellSN (2012) BRCA1 and BRCA2: important differences with common interests. Nat Rev Cancer 12: 372.

4. McKinnonPJ (2009) DNA repair deficiency and neurological disease. Nature reviews Neuroscience 10: 100–112.

5. KatyalS, McKinnonPJ (2008) DNA strand breaks, neurodegeneration and aging in the brain. Mech Ageing Dev 129: 483–491.

6. FuD, CalvoJA, SamsonLD (2012) Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer 12: 104–120.

7. CrosbiePA, WatsonAJ, AgiusR, BarberPV, MargisonGP, et al. (2012) Elevated N3-methylpurine-DNA glycosylase DNA repair activity is associated with lung cancer. Mutat Res 732: 43–46.

8. CerdaSR, TurkPW, ThorAD, WeitzmanSA (1998) Altered expression of the DNA repair protein, N-methylpurine-DNA glycosylase (MPG) in breast cancer. FEBS Lett 431: 12–18.

9. Leitner-DaganY, SevilyaZ, PinchevM, KramerR, ElingerD, et al. (2012) N-Methylpurine DNA Glycosylase and OGG1 DNA Repair Activities: Opposite Associations With Lung Cancer Risk. J Natl Cancer Inst 104(22):1765–1769 doi:10.1093/jnci/djs445.

10. RobertsonAB, KlunglandA, RognesT, LeirosI (2009) DNA repair in mammalian cells: Base excision repair: the long and short of it. Cell Mol Life Sci 66: 981–993.

11. BoiteuxS, GuilletM (2004) Abasic sites in DNA: repair and biological consequences in Saccharomyces cerevisiae. DNA Repair (Amst) 3: 1–12.

12. AndrabiSA, DawsonTM, DawsonVL (2008) Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann N Y Acad Sci 1147: 233–241.

13. SchaaperRM, KunkelTA, LoebLA (1983) Infidelity of DNA synthesis associated with bypass of apurinic sites. Proc Natl Acad Sci U S A 80: 487–491.

14. PagèsV, JohnsonRE, PrakashL, PrakashS (2008) Mutational specificity and genetic control of replicative bypass of an abasic site in yeast. Proc Natl Acad Sci U S A 105: 1170–1175.

15. AvkinS, AdarS, BlanderG, LivnehZ (2002) Quantitative measurement of translesion replication in human cells: Evidence for bypass of abasic sites by a replicative DNA polymerase. Proc Natl Acad Sci U S A 99: 3764–3769.

16. GoodmanMF, CreightonS, BloomLB, PetruskaJ, KunkelTA (1993) Biochemical Basis of DNA Replication Fidelity. Critical Reviews in Biochemistry and Molecular Biology 28: 83–126.

17. StraussBS (1991) The ‘A rule’ of mutagen specificity: a consequence of DNA polymerase bypass of non-instructional lesions? Bioessays 13: 79–84.

18. SobolRW, PrasadR, EvenskiA, BakerA, YangX-P, et al. (2000) The lyase activity of the DNA repair protein [beta]-polymerase protects from DNA-damage-induced cytotoxicity. Nature 405: 807–810.

19. SobolRW, KartalouM, AlmeidaKH, JoyceDF, EngelwardBP, et al. (2003) Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses. J Biol Chem 278: 39951–39959.

20. SaparbaevM, LavalJ (1994) Excision of hypoxanthine from DNA containing dIMP residues by the Escherichia coli, yeast, rat, and human alkylpurine DNA glycosylases. Proc Natl Acad Sci U S A 91: 5873–5877.

21. EngelwardBP, WeedaG, WyattMD, BroekhofJL, de WitJ, et al. (1997) Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc Natl Acad Sci U S A 94: 13087–13092.

22. GallagherPE, BrentTP (1984) Further purification and characterization of human 3-methyladenine-DNA glycosylase. Evidence for broad specificity. Biochim Biophys Acta 782: 394–401.

23. HangB, SingerB, MargisonGP, ElderRH (1997) Targeted deletion of alkylpurine-DNA-N-glycosylase in mice eliminates repair of 1,N6-ethenoadenine and hypoxanthine but not of 3,N4-ethenocytosine or 8-oxoguanine. Proc Natl Acad Sci U S A 94: 12869–12874.

24. MiaoF, BouzianeM, O'ConnorTR (1998) Interaction of the recombinant human methylpurine-DNA glycosylase (MPG protein) with oligodeoxyribonucleotides containing either hypoxanthine or abasic sites. Nucleic Acids Res 26: 4034–4041.

25. O'ConnorTR (1993) Purification and characterization of human 3-methyladenine-DNA glycosylase. Nucleic Acids Research 21: 5561–5569.

26. LeeCY, DelaneyJC, KartalouM, LingarajuGM, Maor-ShoshaniA, et al. (2009) Recognition and processing of a new repertoire of DNA substrates by human 3-methyladenine DNA glycosylase (AAG). Biochemistry 48: 1850–1861.

27. FuD, SamsonLD (2012) Direct repair of 3,N(4)-ethenocytosine by the human ALKBH2 dioxygenase is blocked by the AAG/MPG glycosylase. DNA Repair (Amst) 11: 46–52.

28. RothRB, SamsonLD (2002) 3-Methyladenine DNA glycosylase-deficient Aag null mice display unexpected bone marrow alkylation resistance. Cancer Res 62: 656–660.

29. MeiraLB, Moroski-ErkulCA, GreenSL, CalvoJA, BronsonRT, et al. (2009) Aag-initiated base excision repair drives alkylation-induced retinal degeneration in mice. Proc Natl Acad Sci U S A 106: 888–893.

30. RouleauM, PatelA, HendzelMJ, KaufmannSH, PoirierGG (2010) PARP inhibition: PARP1 and beyond. Nat Rev Cancer 10: 293–301.

31. SchreiberV, DantzerF, AmeJC, de MurciaG (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7: 517–528.

32. KrishnakumarR, GambleMJ, FrizzellKM, BerrocalJG, KininisM, et al. (2008) Reciprocal Binding of PARP-1 and Histone H1 at Promoters Specifies Transcriptional Outcomes. Science 319: 819–821.

33. KrausWL, LisJT (2003) PARP Goes Transcription. Cell 113: 677–683.

34. El-KhamisySF, MasutaniM, SuzukiH, CaldecottKW (2003) A requirement for PARP1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Research 31: 5526–5533.

35. MassonM, NiedergangC, SchreiberV, MullerS, Menissier-de MurciaJ, et al. (1998) XRCC1 Is Specifically Associated with Poly(ADP-Ribose) Polymerase and Negatively Regulates Its Activity following DNA Damage. Mol Cell Biol 18: 3563–3571.

36. VidalAE, BoiteuxS, HicksonID, RadicellaJP (2001) XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. Embo J 20: 6530–6539.

37. AhelD, HořejšíZ, WiechensN, PoloSE, Garcia-WilsonE, et al. (2009) Poly(ADP-ribose)–Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1. Science 325: 1240–1243.

38. TiminszkyG, TillS, HassaPO, HothornM, KustatscherG, et al. (2009) A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat Struct Mol Biol 16: 923–929.

39. GottschalkAJ, TiminszkyG, KongSE, JinJ, CaiY, et al. (2009) Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. Proc Natl Acad Sci USA 106: 13770–13774.

40. HeeresJT, HergenrotherPJ (2007) Poly(ADP-ribose) makes a date with death. Curr Opin Chem Biol 11: 644–653.

41. JozaN, PospisilikJA, HangenE, HanadaT, ModjtahediN, et al. (2009) AIF: not just an apoptosis-inducing factor. Ann N Y Acad Sci 1171: 2–11.

42. SenejaniAG, DalalS, LiuY, NottoliTP, McGrathJM, et al. (2012) Y265C DNA polymerase beta knockin mice survive past birth and accumulate base excision repair intermediate substrates. Proc Natl Acad Sci U S A 109: 6632–6637.

43. TangJ-b, SvilarD, TrivediRN, WangX-h, GoellnerEM, et al. (2011) N-methylpurine DNA glycosylase and DNA polymerase β modulate BER inhibitor potentiation of glioma cells to temozolomide. Neuro-Oncology 13: 471–486.

44. TangJ-b, GoellnerEM, WangX-h, TrivediRN, St CroixCM, et al. (2010) Bioenergetic Metabolites Regulate Base Excision Repair–Dependent Cell Death in Response to DNA Damage. Molecular Cancer Research 8: 67–79.

45. LiuL, GersonSL (2004) Therapeutic impact of methoxyamine: blocking repair of abasic sites in the base excision repair pathway. Curr Opin Investig Drugs 5: 623–627.

46. WilsonD, SimeonovA (2010) Small molecule inhibitors of DNA repair nuclease activities of APE1. Cellular and Molecular Life Sciences 67: 3621–3631.

47. JelezcovaE, TrivediRN, WangX-h, TangJ-b, BrownAR, et al. (2010) Parp1 activation in mouse embryonic fibroblasts promotes Pol [beta]-dependent cellular hypersensitivity to alkylation damage. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 686: 57–67.

48. TrivediRN, WangX-h, JelezcovaE, GoellnerEM, TangJ-b, et al. (2008) Human Methyl Purine DNA Glycosylase and DNA Polymerase β Expression Collectively Predict Sensitivity to Temozolomide. Molecular Pharmacology 74: 505–516.

49. KisbyGE, LesselrothH, OlivasA, SamsonL, GoldB, et al. (2004) Role of nucleotide- and base-excision repair in genotoxin-induced neuronal cell death. DNA Repair (Amst) 3: 617–627.

50. KisbyGE, OlivasA, ParkT, ChurchwellM, DoergeD, et al. (2009) DNA repair modulates the vulnerability of the developing brain to alkylating agents. DNA Repair (Amst) 8: 400–412.

51. WangZQ, AuerB, StinglL, BerghammerH, HaidacherD, et al. (1995) Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes & Development 9: 509–520.

52. TarantinoLM, GouldTJ, DruhanJP, BucanM (2000) Behavior and mutagenesis screens: the importance of baseline analysis of inbred strains. Mammalian Genome 11: 555–564.

53. BrooksSP, PaskT, JonesL, DunnettSB (2004) Behavioural profiles of inbred mouse strains used as transgenic backgrounds. I: motor tests. Genes Brain Behav 3: 206–215.

54. LiuC, TuY, YuanJ, MaoX, HeS, et al. (2012) Aberrant Expression of N-Methylpurine-DNA Glycosylase Influences Patient Survival in Malignant Gliomas. J Biomed Biotechnol 2012: 760679 doi: 10.1155/2012/760679.

55. AgnihotriS, GajadharAS, TernamianC, GorliaT, DiefesKL, et al. (2012) Alkylpurine–DNA–N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients. The Journal of Clinical Investigation 122: 253–266.

56. FishelML, HeY, SmithML, KelleyMR (2007) Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide. Clin Cancer Res 13: 260–267.

57. GouldE (2007) How widespread is adult neurogenesis in mammals? Nat Rev Neurosci 8: 481–488.

58. DurkaczB, OmidijiO, GrayD, ShallS (1980) (ADP-ribose)n participates in DNA excision repair. Nature 283: 593–593.

59. BryantHE, SchultzN, ThomasHD, ParkerKM, FlowerD, et al. (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434: 913–917.

60. FarmerH, McCabeN, LordCJ, TuttANJ, JohnsonDA, et al. (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917–921.

61. Mégnin-ChanetF, BolletM, HallJ (2010) Targeting poly(ADP-ribose) polymerase activity for cancer therapy. Cellular and Molecular Life Sciences 67: 3649–3662.

62. HainceJ-F, RouleauM, HendzelMJ, MassonJ-Y, PoirierGG (2005) Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy. Trends in Molecular Medicine 11: 456–463.

63. StromCE, JohanssonF, UhlenM, SzigyartoCA, ErixonK, et al. (2011) Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate. Nucleic Acids Res 39: 3166–3175.

64. KedarPS, StefanickDF, HortonJK, WilsonSH (2012) Increased PARP-1 Association with DNA in Alkylation Damaged, PARP-Inhibited Mouse Fibroblasts. Molecular Cancer Research 10: 360–368.

65. MaW, HalwegCJ, MenendezD, ResnickMA (2012) Differential effects of poly(ADP-ribose) polymerase inhibition on DNA break repair in human cells are revealed with Epstein–Barr virus. Proceedings of the National Academy of Sciences 109: 6590–6595.

66. MuraiJ, HuangS-yN, DasBB, RenaudA, ZhangY, et al. (2012) Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. Cancer Research 72: 5588–5599.

67. StromCE, JohanssonF, UhlenM, Al-Khalili SzigyartoC, ErixonK, et al. (2010) Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate. Nucleic Acids Res 39(8): 3166–75 doi: 10.1093/nar/gkq1241.

68. HottigerMO, HassaPO, LüscherB, SchülerH, Koch-NolteF (2010) Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends in Biochemical Sciences 35: 208–219.

69. ZongWX, DitsworthD, BauerDE, WangZQ, ThompsonCB (2004) Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 18: 1272–1282.

70. XuY, HuangS, LiuZG, HanJ (2006) Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol Chem 281: 8788–8795.

71. HaHC, SnyderSH (1999) Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 96: 13978–13982.

72. EliassonMJ, SampeiK, MandirAS, HurnPD, et al. (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 10: 1089–1095.

73. MandirAS, PoitrasMF, BerlinerAR, HerringWJ, GuastellaDB, et al. (2000) NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase. J Neurosci 20: 8005–8011.

74. YangZ, ZingarelliB, SzaboC (2000) Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. Shock 13: 60–66.

75. SahabogluA, TanimotoN, KaurJ, Sancho-PelluzJ, HuberG, et al. (2010) PARP1 Gene Knock-Out Increases Resistance to Retinal Degeneration without Affecting Retinal Function. PLoS ONE 5: e15495 doi:10.1371/journal.pone.0015495.

76. LiC, WangL, KernTS, ZhengL (2012) Inhibition of poly(ADP-ribose) polymerase inhibits ischemia/reperfusion induced neurodegeneration in retina via suppression of endoplasmic reticulum stress. Biochemical and Biophysical Research Communications 423: 276–281.

77. Al-AttarA, GossageL, FareedKR, ShehataM, MohammedM, et al. (2010) Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers. Br J Cancer 102: 704–709.

78. SweasyJB, LangT, DiMaioD (2006) Is Base Excision Repair a Tumor Suppressor Mechanism? Cell Cycle 5: 250–259.

79. StarcevicD, DalalS, SweasyJB (2004) Is There a Link Between DNA Polymerase Beta and Cancer? Cell Cycle 3: 996–999.

80. ZarembaT, KetzerP, ColeM, CoulthardS, PlummerER, et al. (2009) Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines. Br J Cancer 101: 256–262.

81. HaoB, WangH, ZhouK, LiY, ChenX, et al. (2004) Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 64: 4378–4384.

82. LockettKL, HallMC, XuJ, ZhengSL, BerwickM, et al. (2004) The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 64: 6344–6348.

83. ZhangX, MiaoX, LiangG, HaoB, WangY, et al. (2005) Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 65: 722–726.

84. BacaliniMG, TavolaroS, PeragineN, MarinelliM, SantangeloS, et al. (2012) A subset of chronic lymphocytic leukemia patients display reduced levels of PARP1 expression coupled with a defective irradiation-induced apoptosis. Experimental Hematology 40: 197–206.

85. HollemanA, BoerMLd, KazemierKM, BeverlooHB, von BerghARM, et al. (2005) Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Blood 106: 1817–1823.

86. DeichmannWB, LeBlancTJ (1943) Determination of the approximate lethal dose with about six animals. Journal of Industrial Hygiene and Toxicology 25: 415–417.